Lichenstein, Sarah D. http://orcid.org/0000-0002-2978-991X
Kohler, Robert
Ye, Fengdan
Potenza, Marc N. http://orcid.org/0000-0002-6323-1354
Kiluk, Brian
Yip, Sarah W. http://orcid.org/0000-0003-2293-2864
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K08DA051667, T32DA007238, R01DA039136, P50DA09241, R01DA020908, R01DA035058, R01DA019039, P50DA09241)
YSM Office of Team Science
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (K02AA027300)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 10 March 2023
Revised: 11 May 2023
Accepted: 1 June 2023
First Online: 12 June 2023
Competing interests
: SDL, RK and FY report no competing financial interests in relation to the work described. MNP has consulted for Opiant Therapeutics, Game Day Data, Baria-Tek, the Addiction Policy Forum, AXA and Idorsia Pharmaceuticals; has been involved in a patent application with Yale University and Novartis; has received research support from Mohegan Sun Casino and the Connecticut Council on Problem Gambling; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse-control disorders or other health topics; has consulted for and/or advised gambling and legal entities on issues related to impulse-control/addictive disorders; has provided clinical care in a problem gambling services program; has performed grant reviews for research-funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. BK is a consultant to CBT4CBT LLC, which makes versions of CBT4CBT (one of the treatments evaluated in the parent RCTs included in this study) available to qualified clinical providers and organizations on a commercial basis. SWF is a consultant for Sparian Biosciences.